| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |